Vor Biopharma Ownership 2024 | Who Owns Vor Biopharma Now?
Institutional Ownership
80.14%
Insider Ownership
1.21%
Retail Ownership
18.65%
Institutional Holders
68.00
Vor Biopharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 33.44% | 0.30% | 22,748,880 | - | - | 22,748,880 | Jun 30, 2024 |
| FMR LLC | 10.40% | 0.00% | 7,075,802 | -532,637 | -7.00% | 7,075,802 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 9.49% | 0.25% | 6,457,293 | - | - | 6,457,293 | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 9.35% | 1.42% | 6,361,723 | - | - | 6,361,723 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 3.71% | 0.03% | 2,525,449 | -657,440 | -20.66% | 2,525,449 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.87% | - | 1,954,285 | 141,386 | 7.80% | 1,954,285 | Jun 30, 2024 |
| JOHNSON & JOHNSON | 1.58% | 0.27% | 1,074,658 | - | - | 1,074,658 | Jun 30, 2024 |
| SARISSA CAPITAL MANAGEMENT LP | 0.91% | 0.10% | 618,000 | - | - | 618,000 | Jun 30, 2024 |
| BLACKROCK INC. | 0.73% | - | 497,696 | -1,749,762 | -77.86% | 497,696 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.73% | 0.00% | 495,300 | 160,642 | 48.00% | 495,300 | Jun 30, 2024 |
| MAI CAPITAL MANAGEMENT | 0.69% | 0.00% | 470,068 | 104,209 | 28.48% | 470,068 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.62% | - | 424,832 | -416,376 | -49.50% | 424,933 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.57% | 0.00% | 389,638 | 231,246 | 146.00% | 389,638 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.56% | 0.00% | 380,743 | -17,619 | -4.42% | 380,743,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.55% | 0.00% | 375,342 | 282,171 | 302.85% | 375,342 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.51% | 0.00% | 346,087 | - | - | 346,087 | Jun 30, 2024 |
| MORGAN STANLEY | 0.25% | - | 169,300 | 42,608 | 33.63% | 169,300 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.24% | 0.00% | 165,900 | 33,200 | 25.02% | 165,900 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.19% | 0.01% | 132,298 | 132,298 | 100.00% | 132,298 | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.17% | 0.00% | 117,788 | -36,648 | -23.73% | 117,788 | Jun 30, 2024 |
Vor Biopharma's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 33.44% of the company's total share outstanding, currently valued at $22.75M. The top 10 institutional shareholders own together 73.22% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| 5AM VENTURE MANAGEMENT, LLC | 9.35% | 1.42% | 6,361,723 | - | - | 6,361,723 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 33.44% | 0.30% | 22,748,880 | - | - | 22,748,880 | Jun 30, 2024 |
| JOHNSON & JOHNSON | 1.58% | 0.27% | 1,074,658 | - | - | 1,074,658 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 9.49% | 0.25% | 6,457,293 | - | - | 6,457,293 | Jun 30, 2024 |
| SARISSA CAPITAL MANAGEMENT LP | 0.91% | 0.10% | 618,000 | - | - | 618,000 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 3.71% | 0.03% | 2,525,449 | -657,440 | -20.66% | 2,525,449 | Jun 30, 2024 |
| GROUND SWELL CAPITAL, LLC | 0.03% | 0.02% | 20,674 | 20,674 | 100.00% | 20,674 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.09% | 0.01% | 63,262 | 63,262 | 100.00% | 63,262 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.19% | 0.01% | 132,298 | 132,298 | 100.00% | 132,298 | Jun 30, 2024 |
| MAI CAPITAL MANAGEMENT | 0.69% | 0.00% | 470,068 | 104,209 | 28.48% | 470,068 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.24% | 0.00% | 165,900 | 33,200 | 25.02% | 165,900 | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.17% | 0.00% | 117,788 | -36,648 | -23.73% | 117,788 | Jun 30, 2024 |
| UNITED BANK | 0.02% | 0.00% | 15,300 | 4,400 | 40.37% | 15,300 | Jun 30, 2024 |
| MONEY CONCEPTS CAPITAL CORP | 0.03% | 0.00% | 20,000 | - | - | 20,000 | Jun 30, 2024 |
| BOLLARD GROUP LLC | 0.08% | 0.00% | 55,555 | - | - | 56,000 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.11% | 0.00% | 77,800 | 77,800 | 100.00% | 77,800 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.05% | 0.00% | 35,100 | 35,100 | 100.00% | 35,100 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.73% | 0.00% | 495,300 | 160,642 | 48.00% | 495,300 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.02% | 0.00% | 12,370 | 12,370 | 100.00% | 12,000 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.51% | 0.00% | 346,087 | - | - | 346,087 | Jun 30, 2024 |
The largest Vor Biopharma shareholder by % of total assets is 5AM VENTURE MANAGEMENT, LLC. The company owns 6.36M shares of Vor Biopharma (VOR), representing 1.42% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 0.55% | 0.00% | 375,342 | 282,171 | 302.85% | 375,342 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.57% | 0.00% | 389,638 | 231,246 | 146.00% | 389,638 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.73% | 0.00% | 495,300 | 160,642 | 48.00% | 495,300 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.87% | - | 1,954,285 | 141,386 | 7.80% | 1,954,285 | Jun 30, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.19% | 0.01% | 132,298 | 132,298 | 100.00% | 132,298 | Jun 30, 2024 |
| MAI CAPITAL MANAGEMENT | 0.69% | 0.00% | 470,068 | 104,209 | 28.48% | 470,068 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.14% | 0.00% | 95,367 | 95,367 | 100.00% | 95,367 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.11% | 0.00% | 77,800 | 77,800 | 100.00% | 77,800 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.09% | 0.01% | 63,262 | 63,262 | 100.00% | 63,262 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.08% | 0.00% | 52,914 | 52,914 | 100.00% | 52,914 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.08% | 0.00% | 52,287 | 52,287 | 100.00% | 52,287 | Jun 30, 2024 |
| MORGAN STANLEY | 0.25% | - | 169,300 | 42,608 | 33.63% | 169,300 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.05% | 0.00% | 35,100 | 35,100 | 100.00% | 35,100 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.24% | 0.00% | 165,900 | 33,200 | 25.02% | 165,900 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.05% | 0.00% | 31,855 | 31,855 | 100.00% | 31,000 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.07% | - | 49,038 | 31,333 | 176.97% | 51,000 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.12% | 0.00% | 81,305 | 27,597 | 51.38% | 79,000 | Jun 30, 2024 |
| GROUND SWELL CAPITAL, LLC | 0.03% | 0.02% | 20,674 | 20,674 | 100.00% | 20,674 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | - | 19,524 | 19,524 | 100.00% | 19,524 | Jun 30, 2024 |
| SEI INVESTMENTS CO | 0.03% | - | 17,596 | 17,596 | 100.00% | 17,596,000 | Jun 30, 2024 |
As of Jun 30 2024, Vor Biopharma's largest institutional buyer is GOLDMAN SACHS GROUP INC. The company purchased 282.17K stocks of VOR, valued at $375.34K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 0.73% | - | 497,696 | -1,749,762 | -77.86% | 497,696 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | - | - | - | -1,111,123 | -100.00% | - | Jun 30, 2024 |
| ARTAL GROUP S.A. | - | - | - | -1,000,000 | -100.00% | - | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 3.71% | 0.03% | 2,525,449 | -657,440 | -20.66% | 2,525,449 | Jun 30, 2024 |
| STATE STREET CORP | 0.17% | - | 115,934 | -541,773 | -82.37% | 115,934,000 | Jun 30, 2024 |
| FMR LLC | 10.40% | 0.00% | 7,075,802 | -532,637 | -7.00% | 7,075,802 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.62% | - | 424,832 | -416,376 | -49.50% | 424,933 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -104,551 | -100.00% | - | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.03% | - | 17,792 | -86,126 | -82.88% | 17,792 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -71,504 | -100.00% | - | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.01% | - | 5,505 | -38,165 | -87.39% | 5,505 | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.17% | 0.00% | 117,788 | -36,648 | -23.73% | 117,788 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -31,835 | -100.00% | - | Jun 30, 2024 |
| BOURGEON CAPITAL MANAGEMENT LLC | - | - | - | -29,450 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.02% | - | 11,201 | -27,182 | -70.82% | 11,201 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -21,867 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -18,809 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -18,645 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.56% | 0.00% | 380,743 | -17,619 | -4.42% | 380,743,000 | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -17,382 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Vor Biopharma's biggest institutional seller is BLACKROCK INC.. The company sold -1.75M shares of VOR, valued at $497.70K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| Y-INTERCEPT (HONG KONG) LTD | 0.19% | 0.01% | 132,298 | 132,298 | 100.00% | 132,298 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.14% | 0.00% | 95,367 | 95,367 | 100.00% | 95,367 | Jun 30, 2024 |
| CENTIVA CAPITAL, LP | 0.11% | 0.00% | 77,800 | 77,800 | 100.00% | 77,800 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.09% | 0.01% | 63,262 | 63,262 | 100.00% | 63,262 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.08% | 0.00% | 52,914 | 52,914 | 100.00% | 52,914 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.08% | 0.00% | 52,287 | 52,287 | 100.00% | 52,287 | Jun 30, 2024 |
| PALOMA PARTNERS MANAGEMENT CO | 0.05% | 0.00% | 35,100 | 35,100 | 100.00% | 35,100 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.05% | 0.00% | 31,855 | 31,855 | 100.00% | 31,000 | Jun 30, 2024 |
| GROUND SWELL CAPITAL, LLC | 0.03% | 0.02% | 20,674 | 20,674 | 100.00% | 20,674 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | - | 19,524 | 19,524 | 100.00% | 19,524 | Jun 30, 2024 |
| SEI INVESTMENTS CO | 0.03% | - | 17,596 | 17,596 | 100.00% | 17,596,000 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.02% | 0.00% | 14,402 | 14,402 | 100.00% | 14,402 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.02% | 0.00% | 12,370 | 12,370 | 100.00% | 12,000 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.02% | 0.00% | 11,328 | 11,328 | 100.00% | 11,328 | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.02% | - | 11,204 | 11,204 | 100.00% | 11,204 | Jun 30, 2024 |
| PROSHARE ADVISORS LLC | 0.01% | - | 5,111 | 5,111 | 100.00% | 5,111 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.01% | - | 3,600 | 3,600 | 100.00% | 3,600,000 | Jun 30, 2024 |
| MACQUARIE GROUP LTD | 0.00% | - | 1,945 | 1,945 | 100.00% | 1,945 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 1,231 | 1,231 | 100.00% | 1,231 | Jun 30, 2024 |
| NBC SECURITIES, INC. | 0.00% | 0.00% | 1,000 | 1,000 | 100.00% | 1,000 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 528 | 528 | 100.00% | 528 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | - | 102 | 102 | 100.00% | 116 | Jun 30, 2024 |
Vor Biopharma's largest new institutional shareholder by number of shares is Y-INTERCEPT (HONG KONG) LTD, purchased 132.30K shares, valued at $132.30K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WOODLINE PARTNERS LP | - | - | - | -1,111,123 | -100.00% | - | Jun 30, 2024 |
| ARTAL GROUP S.A. | - | - | - | -1,000,000 | -100.00% | - | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -104,551 | -100.00% | - | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | - | - | - | -71,504 | -100.00% | - | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | - | - | - | -31,835 | -100.00% | - | Jun 30, 2024 |
| BOURGEON CAPITAL MANAGEMENT LLC | - | - | - | -29,450 | -100.00% | - | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | - | - | - | -21,867 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -18,809 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -18,645 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | - | - | - | -17,382 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -16,550 | -100.00% | - | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | - | - | - | -14,667 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -13,489 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -13,182 | -100.00% | - | Jun 30, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | - | - | - | -3,837 | -100.00% | - | Jun 30, 2024 |
| LEGAL & GENERAL GROUP PLC | - | - | - | -3,627 | -100.00% | - | Jun 30, 2024 |
| AMERITAS INVESTMENT PARTNERS, INC. | - | - | - | -3,111 | -100.00% | - | Jun 30, 2024 |
| COMERICA BANK | - | - | - | -2,661 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -1,506 | -100.00% | - | Jun 30, 2024 |
| AMALGAMATED BANK | - | - | - | -1,270 | -100.00% | - | Jun 30, 2024 |
| ROYAL BANK OF CANADA | - | - | - | -870 | -100.00% | - | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | - | - | - | -45 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -6 | -100.00% | - | Jun 30, 2024 |
Vor Biopharma's largest sold out institutional shareholder by shares sold is WOODLINE PARTNERS LP, sold -1.11M shares, valued at -, as of undefined.
Vor Biopharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY MT VERNON STREET TRUST | 0.08% | 2,270,083 | -89,582 | -3.80% | Feb 29, 2024 |
| FIDELITY CAPITAL TRUST | 0.05% | 610,405 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.05% | 127,500 | -30,000 | -19.05% | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.05% | 24,842 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.03% | 618,395 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,114,702 | - | - | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 61,309 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,852 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 12,572 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,563,243 | -466,158 | -22.97% | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.00% | 316,751 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 70,794 | 11,345 | 19.08% | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 518,141 | -51,472 | -9.04% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 103,918 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.00% | 19,984 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 385,903 | 22,078 | 6.07% | Feb 29, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 140,560 | - | - | Mar 28, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 324 | - | - | Mar 31, 2024 |
| NEXPOINT FUNDS I | 0.00% | 4,441 | - | - | Dec 31, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 3,111 | - | - | Mar 31, 2024 |
| Guardian Variable Products Trust | 0.00% | 16,800 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 28,015 | - | - | Mar 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 80,019 | - | - | Mar 28, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 14,667 | -1,227 | -7.72% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 908 | - | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 6,484 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,313 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 31,931 | -3,332 | -9.45% | Mar 28, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 833 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 11,600 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 2,258 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 2,576 | 722 | 38.94% | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 344 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 161,216 | 16,191 | 11.16% | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 1,294,127 | -9,843 | -0.75% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 40,438 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 69,940 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,500 | - | - | Mar 28, 2024 |
| VALIC Co I | 0.00% | 14,459 | -58 | -0.40% | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 6,354 | -55 | -0.86% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 170 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 5,522 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 471 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 3,503 | - | - | Feb 29, 2024 |
| FIDELITY HASTINGS STREET TRUST | 0.00% | 246,291 | -604 | -0.24% | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 7,882 | 1,425 | 22.07% | Jan 31, 2024 |
| ProFunds | 0.00% | 296 | -21 | -6.62% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 91,035 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 5,520 | 654 | 13.44% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 22 | - | - | Dec 31, 2023 |
| Guggenheim Active Allocation Fund | 0.00% | 113 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 19,087 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 51,509 | - | - | Jan 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 13,478 | - | - | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 34,424 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,219 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 4,268 | -18 | -0.42% | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 4,673 | 3,976 | 570.44% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 9,887 | - | - | Jan 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 28,054 | -1,235 | -4.22% | Mar 31, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 2,407 | - | - | Jan 31, 2024 |
| Bridge Builder Trust | 0.00% | 14,517 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 6,276 | 5,422 | 634.89% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 711 | - | - | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,578 | - | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 163 | 26 | 18.98% | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 4,609 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 5,253 | - | - | Jan 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 3,613 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 2,800 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 1,825 | - | - | Feb 29, 2024 |
Vor Biopharma's largest mutual fund holder by % of total assets is "FIDELITY MT VERNON STREET TRUST", owning 2.27M shares, compromising 0.08% of its total assets.
Vor Biopharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 68 | -2.86% |
| 31 Mar, 24 | 70 | 14.75% |
| 31 Dec, 23 | 61 | - |
| 30 Sep, 23 | 61 | -16.44% |
| 30 Jun, 23 | 73 | 17.74% |
| 31 Mar, 23 | 62 | 3.33% |
| 31 Dec, 22 | 60 | 30.43% |
| 30 Sep, 22 | 46 | - |
| 30 Jun, 22 | 46 | -19.30% |
| 31 Mar, 22 | 57 | -5.00% |
| 31 Dec, 21 | 60 | 11.11% |
| 30 Sep, 21 | 54 | 5.88% |
| 30 Jun, 21 | 51 | 4.08% |
| 31 Mar, 21 | 49 | - |
As of 30 Jun 24, 68 institutions are holding Vor Biopharma's shares, representing a decrease of -2.86% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 54,521,316 | -7.51% |
| 31 Mar, 24 | 58,949,485 | -1.10% |
| 31 Dec, 23 | 59,603,001 | -1.01% |
| 30 Sep, 23 | 60,212,882 | -0.92% |
| 30 Jun, 23 | 60,773,684 | 0.38% |
| 31 Mar, 23 | 60,544,140 | 0.57% |
| 31 Dec, 22 | 60,203,566 | 90.90% |
| 30 Sep, 22 | 31,536,356 | 1.24% |
| 30 Jun, 22 | 31,149,887 | 0.20% |
| 31 Mar, 22 | 31,087,494 | -0.20% |
| 31 Dec, 21 | 31,150,722 | 1.51% |
| 30 Sep, 21 | 30,687,588 | -0.27% |
| 30 Jun, 21 | 30,771,027 | 0.20% |
| 31 Mar, 21 | 30,710,467 | - |
Vor Biopharma (VOR) has 54.52M shares outstanding as of 30 Jun 24, down -7.51% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 80.14% | 1.04% |
| 31 Mar, 24 | 87.73% | 1.13% |
| 31 Dec, 23 | 88.16% | 1.09% |
| 30 Sep, 23 | 89.83% | 1.07% |
| 30 Jun, 23 | 91.71% | 1.10% |
| 31 Mar, 23 | 91.37% | 0.39% |
| 31 Dec, 22 | 152.22% | 2.21% |
| 30 Sep, 22 | 82.97% | 1.20% |
| 30 Jun, 22 | 83.21% | 1.20% |
| 31 Mar, 22 | 83.36% | 1.17% |
| 31 Dec, 21 | 84.34% | 1.22% |
| 30 Sep, 21 | 83.09% | 1.19% |
| 30 Jun, 21 | 83.52% | 0.44% |
| 31 Mar, 21 | 137.94% | - |
As of 30 Jun 24, Vor Biopharma is held by 80.14% institutional shareholders, representing a 1.04% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 39 | 34.48% |
| 31 Mar, 24 | 29 | 7.41% |
| 31 Dec, 23 | 27 | 35.00% |
| 30 Sep, 23 | 20 | -45.95% |
| 30 Jun, 23 | 37 | 8.82% |
| 31 Mar, 23 | 34 | -17.07% |
| 31 Dec, 22 | 41 | 105.00% |
| 30 Sep, 22 | 20 | 5.26% |
| 30 Jun, 22 | 19 | -13.64% |
| 31 Mar, 22 | 22 | -26.67% |
| 31 Dec, 21 | 30 | -6.25% |
| 30 Sep, 21 | 32 | 33.33% |
| 30 Jun, 21 | 24 | -51.02% |
| 31 Mar, 21 | 49 | - |
39 institutional shareholders have increased their position in VOR stock as of 30 Jun 24 compared to 29 in the previous quarter (a 34.48% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 17 | -19.05% |
| 31 Mar, 24 | 21 | 50.00% |
| 31 Dec, 23 | 14 | -12.50% |
| 30 Sep, 23 | 16 | - |
| 30 Jun, 23 | 16 | 60.00% |
| 31 Mar, 23 | 10 | 66.67% |
| 31 Dec, 22 | 6 | -45.45% |
| 30 Sep, 22 | 11 | -26.67% |
| 30 Jun, 22 | 15 | -16.67% |
| 31 Mar, 22 | 18 | 28.57% |
| 31 Dec, 21 | 14 | 7.69% |
| 30 Sep, 21 | 13 | -13.33% |
| 30 Jun, 21 | 15 | - |
| 31 Mar, 21 | - | - |
17 institutional shareholders have reduced their position in VOR stock as of 30 Jun 24 compared to 21 in the previous quarter (a -19.05% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 68 | -2.86% | 54,521,316 | -7.51% | 80.14% | 1.04% | 39 | 34.48% | 17 | -19.05% |
| 31 Mar, 24 | 70 | 14.75% | 58,949,485 | -1.10% | 87.73% | 1.13% | 29 | 7.41% | 21 | 50.00% |
| 31 Dec, 23 | 61 | - | 59,603,001 | -1.01% | 88.16% | 1.09% | 27 | 35.00% | 14 | -12.50% |
| 30 Sep, 23 | 61 | -16.44% | 60,212,882 | -0.92% | 89.83% | 1.07% | 20 | -45.95% | 16 | - |
| 30 Jun, 23 | 73 | 17.74% | 60,773,684 | 0.38% | 91.71% | 1.10% | 37 | 8.82% | 16 | 60.00% |
| 31 Mar, 23 | 62 | 3.33% | 60,544,140 | 0.57% | 91.37% | 0.39% | 34 | -17.07% | 10 | 66.67% |
| 31 Dec, 22 | 60 | 30.43% | 60,203,566 | 90.90% | 152.22% | 2.21% | 41 | 105.00% | 6 | -45.45% |
| 30 Sep, 22 | 46 | - | 31,536,356 | 1.24% | 82.97% | 1.20% | 20 | 5.26% | 11 | -26.67% |
| 30 Jun, 22 | 46 | -19.30% | 31,149,887 | 0.20% | 83.21% | 1.20% | 19 | -13.64% | 15 | -16.67% |
| 31 Mar, 22 | 57 | -5.00% | 31,087,494 | -0.20% | 83.36% | 1.17% | 22 | -26.67% | 18 | 28.57% |
| 31 Dec, 21 | 60 | 11.11% | 31,150,722 | 1.51% | 84.34% | 1.22% | 30 | -6.25% | 14 | 7.69% |
| 30 Sep, 21 | 54 | 5.88% | 30,687,588 | -0.27% | 83.09% | 1.19% | 32 | 33.33% | 13 | -13.33% |
| 30 Jun, 21 | 51 | 4.08% | 30,771,027 | 0.20% | 83.52% | 0.44% | 24 | -51.02% | 15 | - |
| 31 Mar, 21 | 49 | - | 30,710,467 | - | 137.94% | - | 49 | - | - | - |
Vor Biopharma Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Vor Biopharma's stock was made by Attar Eyal C. on Aug 08 2024, selling 999 shares at $0.87 per share (valued at $869.13).
Vor Biopharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 6 | - |
| Q2 2024 | 8 | 14 | 57.14% |
| Q1 2024 | 8 | 7 | 114.29% |
| Q4 2023 | - | 4 | - |
| Q3 2023 | - | 7 | - |
| Q2 2023 | 6 | 4 | 150.00% |
| Q1 2023 | 8 | 3 | 266.67% |
| Q4 2022 | 2 | - | - |
| Q3 2022 | 2 | - | - |
| Q2 2022 | 12 | - | - |
| Q1 2022 | 4 | - | - |
| Q4 2021 | - | 4 | - |
| Q3 2021 | 1 | 1 | 100.00% |
| Q2 2021 | 2 | - | - |
| Q1 2021 | 26 | 33 | 78.79% |
0 total buy trades, and 6 total sell trades (buy/sell ratio of 0.00%) were made by Vor Biopharma's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | 1 | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | 4 | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | 6 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Vor Biopharma's stocks.
Vor Biopharma Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| NUVL | Nuvalent, Inc. |
| NRIX | Nurix Therapeutics, Inc. |
| KYMR | Kymera Therapeutics, Inc. |
| TALS | Tourmaline Bio, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| KNSA | Kiniksa Pharmaceuticals, Ltd. |
| FHTX | Foghorn Therapeutics Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| VTYX | Ventyx Biosciences, Inc. |
| ERAS | Erasca, Inc. |
| BOLT | Bolt Biotherapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| ACLX | Arcellx, Inc. |
| AUTL | Autolus Therapeutics plc |
| ACET | Adicet Bio, Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| STTK | Shattuck Labs, Inc. |
VOR Ownership FAQ
Who Owns Vor Biopharma?
Vor Biopharma is owned by institutional shareholders (80.14%), insiders (1.21%), and public (18.65%). The largest institutional shareholder of Vor Biopharma is RA CAPITAL MANAGEMENT, L.P. (33.44% of total shares) and the top mutual fund owner is FIDELITY MT VERNON STREET TRUST (0.08% of total shares).
Who are the major institutional shareholders of Vor Biopharma?
Vor Biopharma's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., FMR LLC, PARADIGM BIOCAPITAL ADVISORS LP, 5AM VENTURE MANAGEMENT, LLC, and LAURION CAPITAL MANAGEMENT LP. The top five shareholders own together 66.39% of the company's share outstanding.
How many Vor Biopharma shareholders are there?
As of Jun 2024, there are 68 institutional shareholders of Vor Biopharma.
What percentage of Vor Biopharma is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P owns 22.75M shares of Vor Biopharma, representing 33.44% of the company's total shares outstanding, valued at $22.75M (as of Jun 2024).
What percentage of Vor Biopharma is owned by FMR LLC?
As of Jun 2024, FMR LLC holds 7.08M shares of Vor Biopharma (VOR), compromising 10.40% of the company, valued at $7.08M.
What percentage of Vor Biopharma is owned by PARADIGM BIOCAPITAL ADVISORS LP?
PARADIGM BIOCAPITAL ADVISORS LP is the third largest holder of Vor Biopharma. The company owns 6.46M of the company's shares outstanding (worth $6.46M).